Use a DCF anchored on the FCF line. CRWD enters FY2027 with a base of $1.31 billion in FCF and a credible runway to compound that figure at 22-25% for the next three years. The ingredients are visible: module attach rate of approximately 5.0 modules per customer (versus 4.6 a year ago), Falcon Flex contract structure pulling forward consumption, large-customer additions running at record pace, and emerging contribution from cloud-security and identity modules where the growth rate is higher than the consolidated rate.
Assume FY2029 FCF lands at $2.55 billion (a 25% three-year CAGR), and assume the FCF growth rate then settles to a 15% trajectory through FY2033 before a long-run terminal of 4%. Discount at 9.5%. The resulting enterprise value is roughly $148 billion, equating to roughly $605 per share against today's $475. That is a 27% upside if the FCF compounding plays out as modelled.
Now run a more conservative case. FY2029 FCF lands at $2.0 billion (16% three-year CAGR, recognising decelerating growth as scale builds). Discount stays at 9.5%. Enterprise value lands at $112 billion, equating to roughly $460 per share. That implies a 3% downside. The midpoint of these two cases puts fair value at $530, roughly 12% above today's print.
This is, by Valuation Desk standards, a normal upside case for a high-quality platform franchise growing FCF in the high teens to low twenties. The base case is constructive, the downside case is contained, and the upside case is real. Note the framing. The discussion is entirely about FCF growth and discount rates, not about PE multiples. That is the right way to value this kind of business at this stage of its lifecycle.
The Mizuho upgrade and the broader Street commentary on the AI cybersecurity opportunity ($149 billion TAM by 2030 per company estimates) provide directional support, but the case stands on the cash line alone. If FCF compounds at 22%+ for three years, the stock works. If it decelerates to 12-15%, the stock is fairly valued at today's print.